Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2015, GT Healthcare Capital Partners is a venture capital firm based in the United States. The firm specializes in healthcare investments, focusing on medical devices and drug development. GT Healthcare manages a diverse portfolio aimed at enhancing healthcare delivery.
GT Healthcare Capital Partners invests in the healthcare sector, particularly in medical devices and pharmaceuticals. They support companies at various stages, from pre-seed to growth equity, with a focus on technologies that can significantly impact patient care and healthcare systems.
Notable portfolio companies include Oxford Nanopore, developer of the MinION DNA sequencing device; Potrero Medical, known for its FDA-designated Accuryn-AKI predictive algorithm; Moon Surgical, which raised $31 million in Series A funding; and ONI, which completed a $75 million Series B funding round.
Submit your pitch through their form at gthcap.com.
Yes, GT Healthcare often leads investment rounds, particularly in early-stage companies within their focus sectors.
The firm is open to follow-on investments, especially for companies that demonstrate strong growth and alignment with their investment thesis.
GT Healthcare Capital Partners manages a fund size of approximately $200 million, focusing on healthcare innovations.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.